PharmaVOICE - 
March 2014
Purchase Issue

In Every Issue
Talent Pool
Pharma Pool Albert BOURLA Susan SILBERMANN Pfizer Makes Executive Moves [...]
By

Ann Grey

On the Calendar
On the Calendar The Calendar Industry Events and Conferences, including [...]
By

Heather Hummel

PharmaTrax
Pharma Trax Sales, marketing, And R&D?Trends affecting the healthcare industry [...]
By

Denise Myshko

Tools of the Trade
Tools of the Trade Trending Now: The new platform aims [...]
By

Denise Myshko

What’s New
Industry Veterans Bring 360 Degree Insight to Developing Managed Market [...]
By

Ann Grey

Social Buzz
New Social Media News, Events, and Strategies Featured Briefs: J&J [...]
By

Taren Grom, Editor

Innovator’s Corner
Innovators’ Corner From apps to wearable devices, ­technology is helping [...]
By

Denise Myshko and Robin Robinson

UpFront
UpFront A brief review of industry news at press time [...]
By

Denise Myshko

Letter from the Editor
A Connected Healthcare Ecosystem A look at the future of [...]
By

Taren Grom, Editor

On The Cover

Connected Health
Connected Health According to Accenture, the future of healthcare is an ecosystem that is based on connecting all parts of a healthcare delivery system, seamlessly, through interoperable health information processes and technologies so that critical health information is available when and where it is needed. This special issue aims to provide a framework around the [...]
By

Taren Grom, Editor

Features

What’s Next for Biosimilars?
Biologics, whose active substance is derived from a living organism, have enabled healthcare to make significant therapeutic advances across a whole raft of therapy areas since their introduction in the 1970s. However, these medicines come at a price, reflecting the complexities involved in developing and manufacturing products derived from living cells. Annual treatment costs in [...]
By

Harriet Kozak, President, U.S. Office, Research Partnership

Read This Before Your Next Marketing Pilot Exercise
Read This Before Your Next Marketing Pilot Exercise Pilot, or Proof of Concept (PoC), programs have been a marketing staple for ages but the pace has picked up over the past few years thanks in part to the drive for marketing accountability. Unfortunately, these programs continue to be shortchanged on proper evaluation in spite of [...]
By

Peter Von Bartheld, Associate Director, Consulting, Ogilvy Healthworld, part of Ogilvy CommonHealth Worldwide

MCM Analytics: Bright Future Despite It’s Challenges
Analytics is an integral, inseparable element of multichannel marketing (MCM), which is an increasingly essential approach to pharmaceutical marketing. However, we are still far from realizing the full potential of empirically driven audience-level multichannel marketing. This piece highlights the challenges against the full realization of analytics in the MCM arena and encourages the maximization of [...]
By

Senior Director of Analytics, Ogivly Health World, part of Ogilvy CommonHealth Worldwide

Insights Hidden in Data Represent Opportunities for Drug and Medical Device Developers
As speed and cost become increasingly important in health care, more and more decision making will be “shared,” requiring increased data transparency, collection and analysis. Pharmaceutical and medical device innovators can now generate substantial value across the health care spectrum by leveraging this data to improve decision making, optimize innovation, improve the efficiency of research [...]
By

Doug Dockhorn, President and Ceo, Accelerated Vision

SHOWCASE FEATURE: Market Research: Data Points
SHOWCASE FEATURE: Market Research Data points: With increasing amounts of data available, companies need to ­understand what to do and how to use the vast amount of information available at their fingertips to gain a ­competitive advantage. According to research from Urch Publishing, the global pharmaceutical industry is expected to be valued at more than [...]
By

Taren Grom, Editor

Regulating in the Connected Health World
Regulating in the Connected Health World U.S. regulators have issued guidances to help bring clarity to companies considering mHealth. By Denise Myshko Regulation, by its nature, hinders some activity, says Napoleon Monroe, managing director, New Directions. “But regulation is also necessary to ensure product safety and efficacy, and an efficient, functional capital market,” he says. [...]
By

Denise Myshko

mHealth Tools Can Streamline Clinical Trials
mHealth Tools Can Streamline Clinical Trials Studies show that mobile tools increase trial engagement while lowering costs. By Robin Robinson You may be holding the most important medical devices of the future in your hand: a smartphone and a mobile app. As the clinical trial space explores ways to leverage the personal and ubiquitous nature [...]
By

Robin Robinson

Connected Health Tools Improve Patient Outcomes
connected Health Tools Improve Patient Outcomes The ability for real-time information exchange enables better relationships, monitoring, and behavior change. By Robin Robinson The Center for Connected Health has been studying the effects of connected health on patient behavior, engagement, and outcomes and has determined that subjects who used wireless devices as opposed to those who [...]
By

Robin Robinson

mHealth: Patient Adherence Tools Get Personal
mhealth Patient Adherence Tools Get Personal From blister packaging to text reminders, mHealth technology tools are helping drive patient adherence. Acharacteristically slow-moving pharma industry is being hit with technology that is changing at warp speed. How companies prepare for the coming years of groundbreaking innovations in healthcare technology will be crucial in maintaining their relevance [...]
By

Robin Robinson

A Connected Market
Connected health is a vision of the efficiencies that technology can bring to healthcare to improve care and reduce costs. In 10 years, connected health will be the way health is managed. Connected health is a vision of the efficiencies that technology can bring to healthcare to improve care and reduce costs. According to Accenture, [...]
By

Denise Myshko

FEEDBACK